Why the study?
Missense mutations in SCN5A alter Nav1.5 inactivation time constants and cause cardiac diseases, prompting a correlation of mutation locations in the inactivation gate to specific phenotypes.
This review highlights how specific missense mutations in the Nav1.5 inactivation gate correlate with distinct arrhythmia phenotypes, such as long QT syndrome type 3.
Answers are grounded in this paper and cite their sources.
Nav1.5 kinetics underpin phase 0 depolarization; leaves open targeted arrhythmia therapies pending clinical validation.
Nav1.5 is the main voltage-gated sodium channel found in cardiac muscle, where it facilitates the fast influx of Na+ ions across the cell membrane, resulting in the fast depolarization phase—phase 0 of the cardiac action potential. As a result, it plays a major role in determining the amplitude and the upstroke velocity of the cardiac impulse. Quantitively, cardiac sodium channel activates in less than a millisecond to trigger the cardiac action potential and inactivates within 2–3 ms to facilitate repolarization and return to the resting state in preparation for firing the next action potential. Missense mutations in the gene that encodes Nav1.5 (SCN5A), change these time constants which leads to a wide spectrum of cardiac diseases ranging from long QT syndrome type 3 (LQT3) to sudden cardiac death. In this mini-review I will focus on the missense mutations in the inactivation gate of Nav1.5 that results in arrhythmia, attempting to correlate the location of the missense mutation to their specific phenotype.
No takes yet. Share an insight, caveat, or question.
Tamer M. Gamal El-Din (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: